FDA Recall Terminated

AsthmaNefrin Starter Kit contains ten (10) AsthmaNefrin vials and one (1) EZ Breathe Atomizer. For the delivery of liquid medications for respiratory usage.

Recall: Z-1372-2013 · Initiated April 30, 2013

Recall

Recall Number
Z-1372-2013
Event Number
65070
Firm
Nephron Pharmaceuticals Corp.
FEI Number
3010892830
Product Code
CCQ
Status
Terminated
Root Cause
Nonconforming Material/Component
Initiated
April 30, 2013
Posted
May 29, 2013
Terminated
June 28, 2016
Address
4121 SW 34th St, Orlando, FL, 32811-6475

Description

AsthmaNefrin Starter Kit contains ten (10) AsthmaNefrin vials and one (1) EZ Breathe Atomizer. For the delivery of liquid medications for respiratory usage.

Reason

Possible dislodgement of the "Plate A", if this instance occurs, it presents a potential choking hazard.

Action

The firm, Nephron Pharmaceuticals Corporation, notified its consignees on April 30, 2013, and May 3, 2013, of the problem via a recall notice and a Press Release, respectively. The firm directed consignees to discontinue use of any EZ Breathe atomizer units contained in the Asthmanefrin Starter Kits with the affected lot numbers and also those that were sold individually. Customers were directed to return all affected product.

Distribution

Worldwide Distribution-USA (nationwide) including DC and Puerto Rico and the states of AL, AZ, CA, CO, CT, FL, IL, IN, IO, GA, KS, KY, LA, MD, MN, MS, MO, NK, NV, NJ, NM, NY, OH, OK, OR, PA, RI, SC, TN , TX, VT, VA, WA, and WV, and the countries of Guatemala, Poland, Panama, and United Kingdom.

Quantity

241,538 kits